Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2009

01-12-2009 | Short Report

Secondary disorders of glycosylation in inborn errors of fructose metabolism

Authors: E. Quintana, L. Sturiale, R. Montero, F. Andrade, C. Fernandez, M. L. Couce, R. Barone, L. Aldamiz-Echevarria, A. Ribes, R. Artuch, P. Briones

Published in: Journal of Inherited Metabolic Disease | Special Issue 1/2009

Login to get access

Summary

Adamowicz and colleagues raised the alert in 2007 about patients with atypical hereditary fructose intolerance (HFI) primarily misdiagnosed as CDG Ix. We describe a girl with neonatal hypertonia, facial trismus, absent swallowing and coughing reflexes, gastro-oesophageal reflux and sporadically elevated Krebs cycle metabolites and lactate. At 14 months microcephaly and hepatomegaly were noted, with hypertransaminasaemia but normal blood coagulation, glucose, phosphate, and absent urinary reducing substances. Neurological impairment persisted. Because of hepatic and neurological abnormalities with developmental delay, Tf IEF was performed and showed a severe type 1 pattern, resulting in a wrong diagnosis of CDG. Subsequently, an aversion to fruits suggested HFI, confirmed by the finding of ALDOB mutations (p.A150P/p.N335K). The girl improved with fructose-free diet, but liver cirrhosis led to hepatic transplantation. She is now 7 years old with good evolution; facial trismus and hypertonia reversed, but microcephaly persists. Transferrin MALDI-TOF MS characterization revealed underoccupation of glycosylation sites and glycan abnormalities, which reversed with dietary treatment. High maternal fructose concentrations might have caused neonatal abnormalities. Although in our patient’s mother there is no fructose accumulation at present, it is possible that increased ingestion of fruits and vegetables during pregnancy, together with her heterozygosity, caused an accumulation of fructose that finally affected the fetus. We also describe slightly abnormal transferrin isoelectric focusing and MALDI-TOF MS patterns of intact transferrin and N-glycans in a fructose-1,6-bisphosphatase (FBP1)-deficient patient. While HFI is a well-known cause of secondary CDG, we found no reports of abnormal transferrin isoelectric focusing patterns in FBP1 deficiency and we introduce this condition as a possible secondary cause for altered transferrin isoelectric focusing.
Literature
go back to reference Adamowicz M, Ploski R, Rokicki D et al (2007) Transferrin hypoglycosylation in hereditary fructose intolerance: using the clues and avoiding the pitfalls. J Inherit Metab Dis 30:407PubMedCrossRef Adamowicz M, Ploski R, Rokicki D et al (2007) Transferrin hypoglycosylation in hereditary fructose intolerance: using the clues and avoiding the pitfalls. J Inherit Metab Dis 30:407PubMedCrossRef
go back to reference Colomé C, Ferrer I, Artuch R, Vilaseca A, Pineda M, Briones P (2000) Personal experience with the application of CDT assays to the detection of Congenital Disorders of Glycosylation. Clin Chem Lab Med 38:965–969PubMedCrossRef Colomé C, Ferrer I, Artuch R, Vilaseca A, Pineda M, Briones P (2000) Personal experience with the application of CDT assays to the detection of Congenital Disorders of Glycosylation. Clin Chem Lab Med 38:965–969PubMedCrossRef
go back to reference Comunale MA, Lowman M, Long RE et al (2006) Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 5:308–315PubMedCrossRef Comunale MA, Lowman M, Long RE et al (2006) Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 5:308–315PubMedCrossRef
go back to reference Jaeken J, Pirard M, Adamowicz M, Pronicka E, Van Schaftingen E (1996) Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res 40:764–766PubMedCrossRef Jaeken J, Pirard M, Adamowicz M, Pronicka E, Van Schaftingen E (1996) Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res 40:764–766PubMedCrossRef
go back to reference Jaeken J, Matthijs G, Carchon H, Van Schaftingen E (2001) Defects of N-glycan synthesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1601–1622 Jaeken J, Matthijs G, Carchon H, Van Schaftingen E (2001) Defects of N-glycan synthesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1601–1622
go back to reference Morelle W, Flahaut C, Michalski JC, Louvet A, Mathurin P, Klein A (2006) Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. Glycobiology 16:281–293PubMedCrossRef Morelle W, Flahaut C, Michalski JC, Louvet A, Mathurin P, Klein A (2006) Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. Glycobiology 16:281–293PubMedCrossRef
go back to reference Sánchez-Gutiérrez JC, Benlloch T, Leal MA, Samper B, García-Ripoll I, Felíu JE (2002) Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain. J Med Genet 39:56CrossRef Sánchez-Gutiérrez JC, Benlloch T, Leal MA, Samper B, García-Ripoll I, Felíu JE (2002) Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain. J Med Genet 39:56CrossRef
go back to reference Steinmann B, Gitzelmann R, Van den Berghe G (2001) Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1489–1520 Steinmann B, Gitzelmann R, Van den Berghe G (2001) Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1489–1520
go back to reference Sturiale L, Barone R, Fiumara A et al (2005) Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 15:1268–1276PubMedCrossRef Sturiale L, Barone R, Fiumara A et al (2005) Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 15:1268–1276PubMedCrossRef
go back to reference Wada Y, Nishikawa A, Okamoto N et al (1992) Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun 189:832–836PubMedCrossRef Wada Y, Nishikawa A, Okamoto N et al (1992) Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun 189:832–836PubMedCrossRef
go back to reference Wopereis S, Grünewald S, Morava E et al (2003) Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin Chem 49:1839–1845PubMedCrossRef Wopereis S, Grünewald S, Morava E et al (2003) Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin Chem 49:1839–1845PubMedCrossRef
Metadata
Title
Secondary disorders of glycosylation in inborn errors of fructose metabolism
Authors
E. Quintana
L. Sturiale
R. Montero
F. Andrade
C. Fernandez
M. L. Couce
R. Barone
L. Aldamiz-Echevarria
A. Ribes
R. Artuch
P. Briones
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 1/2009
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1219-4

Other articles of this Special Issue 1/2009

Journal of Inherited Metabolic Disease 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.